Generic medicine

Adalimumab

Adalimumab · ATC L04 · Oncology & immunology · Immunosuppressants / immunomodulators

Data statusRegistration & price fields require source verification.

1brand families

1registered presentations

1companies

1with current prices

Available dosage forms

Choose a form

Tap a form to filter the brand list

Injection1 product Clear form filter ×

Advertisement · clearly labelled sponsored placement

Pakistan brand index

Available brands

One brand is shown once per manufacturer; strengths, forms, packs and DRAP registrations remain visible as separate presentations.

Print / Save PDFAll 1 presentations Filtered1 presentations 1 brands · 1 presentations

Brand	Manufacturer	Registered presentations
Dalimab1 presentation	The Searle Company Limited	40 mg/0.8 mL Prefilled syringe injection 1's 115136 PKR 63,329.852026-07-23 PKR 63,329.85/ syringe

Price movement

Official price changes for Adalimumab

No change in the official DRAP price is recorded yet for any of the 1 tracked presentations (records from 23 Jul 2026).

Independent editorial layer

Medicine information

Clinical monographs should be independently written, referenced and medically reviewed. Product listings and advertisements must not determine clinical conclusions.

Cite this record

Molecule record · ATC L04

MedInfoBase. (2026). Adalimumab — registered brands and price distribution in Pakistan [Data set]. MedInfoBase. Retrieved September 24, 2026, from https://medinfobase.com/generic/adalimumab/ ATC L04.

Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.